v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Cash flows from operating activities:    
Net income $ 107,015 $ 104,137
Adjustments to reconcile net income to cash (used in) provided by operating activities:    
Depreciation and amortization 97,981 92,461
Stock-based compensation 9,089 0
Noncash charges for interest and bond discount amortization 9,352 15,078
Amortization of operating lease asset 62,065 64,567
Deferred income taxes (26,854) (20,493)
Loss on foreign exchange 45,493 8,163
Loss on write-down of assets held for sale (32,757) 0
Other (4,896) (6,803)
Changes in operating assets and liabilities, net of effects of acquisitions:    
Trade accounts receivable 463,238 600,052
Inventory (623,888) (163,490)
Other assets (187,387) (65,273)
Accounts payable (132,604) (257,156)
Change in book overdrafts (184,060) 92,193
Operating lease liabilities (87,639) (62,520)
Accrued expenses and other (78,052) (99,998)
Cash (used in) provided by operating activities (498,390) 300,918
Cash flows from investing activities:    
Capital expenditures (64,961) (68,688)
Proceeds from deferred purchase price of factored receivables 141,445 128,515
Issuance of notes receivable (12,501) (43,374)
Proceeds from notes receivable 20,510 21,597
Proceeds from sale of equity investments 20,805 7,670
Other 11,420 1,347
Cash provided by investing activities 116,718 47,067
Cash flows from financing activities:    
Dividends paid to stockholders (40,828) (6,174)
Change in unremitted cash collections from servicing factored receivables (3,587) (8,630)
Repayment of Term Loans (125,000) (150,000)
Gross proceeds from other debt 29,820 41,826
Gross repayments of other debt (32,574) (49,833)
Net proceeds (repayments) from revolving and other credit facilities 452,161 (136,918)
Other (7,019) (934)
Cash provided by (used in) financing activities 272,973 (310,663)
Effect of exchange rate changes on cash and cash equivalents 46,966 (57,050)
Decrease in cash and cash equivalents (61,733) (19,728)
Cash and cash equivalents at beginning of period 918,401 948,490
Cash and cash equivalents at end of period 856,668 928,762
Supplemental disclosure of non-cash investing information:    
Amounts obtained as a beneficial interest in exchange for transferring trade receivables in factoring arrangements $ 128,961 $ 124,809